Zealand Pharma

This study tests the long-term safety of glepaglutide in people with short bowel syndrome, a condition where the body can't absorb enough nutrients from food. About 145 patients who completed earlier trials are taking part. The goal is to see if the drug is safe over time and hel…

This study looks at the long-term safety and effectiveness of a drug called glepaglutide for adults with short bowel syndrome, a condition where the body can't absorb enough nutrients from food. Participants who completed a previous trial will receive weekly injections for about …

This study tests a new weekly injection called petrelintide in 221 adults who are overweight or obese and have type 2 diabetes. The goal is to see if it helps with weight loss and blood sugar control compared to a placebo. Participants must be on stable diabetes medication like m…

This study looks at the long-term safety of dasiglucagon, a drug given as a continuous shot under the skin, in children with congenital hyperinsulinism (CHI), a rare condition that causes dangerously low blood sugar. The trial includes 42 children who already completed a previous…

This study looks at the long-term safety and effectiveness of a drug called glepaglutide in adults with short bowel syndrome (SBS). Participants who were already in earlier trials can continue treatment for up to 2 years. The goal is to see if the drug remains safe and helps redu…